10 insiders reported 17 Form 4 transactions for Evoke Pharma Inc (EVOK) over the past 18 months (most recent 2025-12-19). Recent activity: Mack Daniel (Insider) Sell 148,153 shares, Harkey Wilmot B. (Insider) Sell 148,153 shares, Nantahala Capital Management, LLC (Insider) Sell 148,153 shares, Hill Malcolm R (Director) Sell 133 shares, CARLSON MARILYN R. (Chief Medical Officer) Sell 360 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-19 | Mack Daniel | Insider | Sell | 148,153 | $1.6M |
| 2025-12-19 | Harkey Wilmot B. | Insider | Sell | 148,153 | $1.6M |
| 2025-12-19 | Nantahala Capital Management, LLC | Insider | Sell | 148,153 | $1.6M |
| 2025-12-17 | Hill Malcolm R | Director | Sell | 133 | $0 |
| 2025-12-17 | CARLSON MARILYN R. | Chief Medical Officer | Sell | 360 | $0 |
| 2025-12-17 | GARNER CAM L | Director | Sell | 2,330 | $0 |
| 2025-12-17 | Kowieski Mark | Chief Financial Officer | Sell | 11,815 | $0 |
| 2025-12-17 | D'Onofrio Matthew J | Chief Executive Officer | Sell | 15,509 | $0 |
| 2025-12-17 | Brady Todd C | Director | Sell | 27 | $0 |
| 2025-11-07 | Klein Roger M. | Insider | Sell | 5,000 | $53,300 |
| 2025-11-07 | Klein Roger M. | Insider | Sell | 4,000 | $42,600 |
| 2025-03-24 | D'Onofrio Matthew J | Chief Executive Officer | Buy | 1,000 | $2,800 |
| 2025-03-24 | Kowieski Mark | Chief Financial Officer | Buy | 4,500 | $14,445 |
| 2025-03-03 | D'Onofrio Matthew J | Chief Executive Officer | Buy | 6,849 | $24,999 |
| 2025-01-30 | Nantahala Capital Management, LLC | Insider | Sell | 41 | $180 |
| 2025-01-30 | Mack Daniel | Insider | Sell | 41 | $180 |
| 2025-01-30 | Harkey Wilmot B. | Insider | Sell | 41 | $180 |
Source: SEC Form 4 filings · as of 2025-12-19
